Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data. [electronic resource]
Producer: 20170117Description: 427-437 p. digitalISSN:- 1179-187X
- Antihypertensive Agents -- adverse effects
- Cardiovascular Diseases -- chemically induced
- Cardiovascular System -- drug effects
- Clinical Trials as Topic
- Double-Blind Method
- Drug Therapy, Combination -- adverse effects
- Humans
- Olmesartan Medoxomil -- adverse effects
- Randomized Controlled Trials as Topic
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.